A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2018.
Главный автор: | Haque, Mushfiqul |
---|---|
Другие авторы: | Kabir, Md. Tanvir |
Формат: | Project report |
Язык: | English |
Опубликовано: |
BRAC University
2019
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/11070 |
Схожие документы
-
Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
по: Ishrat, Nowshin
Опубликовано: (2024) -
Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
по: Alam, Badrul, и др.
Опубликовано: (2016) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024) -
A review on artemisinin based combination therapy for the treatment of Malaria
по: Chowdhury, Amina Ferdous
Опубликовано: (2020) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
по: Alim, Abdul
Опубликовано: (2023)